Biotech Medics Valuation
| BMCS Stock | USD 0.01 0.00 0.00% |
Biotech Medics seems to be fairly valued based on Macroaxis valuation methodology. Our model approximates the value of Biotech Medics Ne from analyzing the firm fundamentals such as Current Valuation of 9.68 M, price to earning of (0.47) X, and Profit Margin of (1.29) % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Biotech Medics' price fluctuation is out of control at this time. Calculation of the real value of Biotech Medics Ne is based on 3 months time horizon. Increasing Biotech Medics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Biotech pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Biotech Medics Ne. Since Biotech Medics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biotech Pink Sheet. However, Biotech Medics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.01 | Real 0.009765 | Hype 0.01 |
The intrinsic value of Biotech Medics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biotech Medics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biotech Medics Ne helps investors to forecast how Biotech pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biotech Medics more accurately as focusing exclusively on Biotech Medics' fundamentals will not take into account other important factors: Biotech Medics Total Value Analysis
Biotech Medics Ne is currently forecasted to have valuation of 9.68 M with market capitalization of 870.4 K, debt of 0, and cash on hands of 1.31 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Biotech Medics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.68 M | 870.4 K | 0 | 1.31 K |
Biotech Medics Investor Information
The company recorded a loss per share of 0.0. Biotech Medics Ne had not issued any dividends in recent years. The entity had 1:20 split on the 16th of November 2007. Based on the key indicators related to Biotech Medics' liquidity, profitability, solvency, and operating efficiency, Biotech Medics Ne is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Biotech Medics Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Biotech implies not a very effective usage of assets in March.Biotech Medics Profitability Analysis
The company reported the previous year's revenue of 469.8 K. Net Loss for the year was (603.72 K) with profit before overhead, payroll, taxes, and interest of 408.14 K.About Biotech Medics Valuation
The pink sheet valuation mechanism determines Biotech Medics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Biotech Medics Ne based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biotech Medics. We calculate exposure to Biotech Medics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biotech Medics's related companies.BioTech Medics, Inc. operates as a medical-based holding company. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida. Biotech Medics is traded on OTC Exchange in the United States.
8 Steps to conduct Biotech Medics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Biotech Medics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Biotech Medics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Biotech Medics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Biotech Medics' revenue streams: Identify Biotech Medics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Biotech Medics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Biotech Medics' growth potential: Evaluate Biotech Medics' management, business model, and growth potential.
- Determine Biotech Medics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Biotech Medics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Biotech Medics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Biotech Medics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -1.8 M |
Additional Tools for Biotech Pink Sheet Analysis
When running Biotech Medics' price analysis, check to measure Biotech Medics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Medics is operating at the current time. Most of Biotech Medics' value examination focuses on studying past and present price action to predict the probability of Biotech Medics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Medics' price. Additionally, you may evaluate how the addition of Biotech Medics to your portfolios can decrease your overall portfolio volatility.